A new Phase 2 pilot study shows that giving spores of a non-toxic C. difficile bacteria by mouth is effective in stopping repeated bouts of C. diff infection, a major […]
Featured Posts
Fructose has, in recent years, become almost another f-word to avoid using, as it’s been implicated in certain health concerns, from metabolic problems to impaired cognitive function. Now, a new study in […]
Antisense Approach for Clotting Disorders Whippany, NJ – WEBWIRE – Monday, May 04, 2015 Bayer HealthCare (Bayer) has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) […]
At the recent American Association of Cancer Research (AACR) meeting, one of the most encouraging sets of presentations pertained to PARP inhibitors. What’s emerging is that this new class of […]
“We produced a mutant enzyme that is very efficient at cutting off the sugars in A and B blood, and is much more proficient at removing the subtypes of the […]
LOS ANGELES–(BUSINESS WIRE)–Today AIDS Healthcare Foundation President Michael Weinstein issued the following statement on findings recently published in the Antimicrobial Agents and Chemotherapy report that scientists from the Oak Crest […]
PARIS & ROUEN, France–(BUSINESS WIRE)–PlugMed has been awarded €2 million of funding, as part of the World Innovation Challenge organized by the French Ministry of Industry. The funding will enable […]
If your job is chock full of challenging thinking tasks, your brain may be getting a positive boost that will help prevent memory loss and thinking decline later in life, […]
Nutra Pharma Has Announced That They Have Received Notification of the Acceptance of Nyloxin® by the China International Exchange and Promotive Association for Medical and Healthcare (CPAM) CORAL SPRINGS, FL–(Marketwired […]
Two days after the U.S. Food & Drug Administration signaled it might quash Amgen Inc.’s attempt to usher in a whole new class of virus-based cancer drugs, an advisory panel […]